Over the past 15 years, the Biometrics group within CROMSOURCE has conducted hundreds of important projects either as part of full-service agreements or as stand-alone assignments across all segments of the healthcare research sector, including medical devices, pharmaceuticals, biotechnologies and vaccines’, noted Hugo Hartmans, Director of Biometrics.

We consistently delight our clients by delivering high quality services and proactively searching for the most efficient solution.As part of this commitment to satisfy our clients’ needs, evidenced by our 80% repeat business level, CROMSOURCE decided to invest in upgrading to the latest Oracle Clinical Release.’

Key benefits of the upgrade include availability of web-based randomisation, provision of email alerts on entry of certain defined data (e.g. SAEs), increased flexibility of eCRF design and flow, conditional navigation and other increases in general usability. The combined effect of these changes is to increase the ease, speed and accuracy of data handling which in turn creates cleaner data, faster. The upgraded version of Oracle Clinical and Remote Data

Capture (RDC) is now installed and hosted on the state-of-the-art infrastructure in the CROMSOURCE European Headquarters, and is fully validated and maintained in accordance with all applicable international guidelines.

This is an important milestone and reflects our commitment to remaining at the forefront of technological innovation and providing best in class solutions to our clients‘ stated Oriana Zerbini MD, Chief Executive Officer of CROMSOURCE.

CROMSOURCE has an enviable record of delivering high quality statistics and data management projects to our sponsors on time, on budget and to the highest quality. I am convinced that this development will create many added benefits for our clients